Advertisement

Getting the Treatment

  • Anne Rogers
  • David Pilgrim
  • Ron Lacey
Chapter
Part of the Issues in Mental Health book series (IMH)

Abstract

In this chapter we look at people’s experience of psychiatric treatment. Under British mental health law the term medical treatment includes ‘nursing, and also includes care, habilitation and rehabilitation under medical supervision’ (Section 145(1), Mental Health Act 1983). This legal definition of treatment reflects and underlines the pre-eminence of the medical model and the medical profession in mental health services. Here we limit the use of the term ‘treatment’ to describe people’s experiences of interventions that are specifically directed toward the control of symptoms, such as drugs, ECT, and various ‘talking treatments’. Our data suggest that these treatments are experienced by patients as a fixed part the daily routine of services, rather than regimes tailored to people’s individual needs or preferences. Most patients appear to have received most of the available treatments (in particular, drugs) for most of the time. Thus, whether diagnosed as suffering from schizophrenia or from depression, a majority (56.4 per cent) reported receiving anti-psychotic medication, anti-depressants and minor tranquillisers concurrently. Of those who received antipsychotic drugs, more than half (51.9 per cent) received them as depot injections and in tablet or tot form concurrently.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Notes and References

  1. 1.
    Sheppard, C., Collins, L., Florentino, D., Fracchia, J and Merliss, S., ‘Polypharmacy in Psychiatric Treatment: 1. Incidence at a State Hospital’, Current Therapeutic Research, 11 (1969), pp. 765–74;Google Scholar
  2. 1a.
    Skippard, C., Merliss, S. and Collins, L., ‘Polypharmacy in Psychiatry; Patterns of Differential Treatment’, American Journal of Psychiatry, 126 (1970), pp. 123–7;Google Scholar
  3. 1b.
    Herxheimer, A., ‘Ignorance, Educating Doctors to Use Drugs Well’, British Journal of Clinical Pharmacology, 3 (1976), pp. 111–12;CrossRefGoogle Scholar
  4. 1c.
    Hemmenki, E., ‘Polypharmacy among Psychiatric Patient’, Acta Psychiatrica Scandinavica, 56 (1977), pp. 347–56;CrossRefGoogle Scholar
  5. 1d.
    Marks, I., ‘The Doctor, the Patient and Psychotropic Drugs’, Update (May 1977), pp. 1195–200;Google Scholar
  6. 1e.
    Michel, K. and Kolakowska, T., ‘A Survey of Psychotropic Drug Prescribing in Two Psychiatric Hospitals’, British Journal of Psychiatry, 138 (1981), pp. 217–21;CrossRefGoogle Scholar
  7. 1f.
    Edwards, S. and Kumar, V., ‘A Survey of Prescribing of Psychotropic Drugs in a Birmingham Psychiatric Hospital’, British Journal of Psychiatry, 145 (1984), pp.502–7;CrossRefGoogle Scholar
  8. 1g.
    Clark A. F. and Holden, N. L., ‘The Persistence of Prescribing Habits: A Survey and Follow-Up of Prescribing to Chronic Hospital In-Patients’, British Journal of Psychiatry, 150 (1987), 88–91;CrossRefGoogle Scholar
  9. 1h.
    Johnson, D.A.W. and Wright, N. F., ‘Drug Prescribing for Schizophrenic Out-Patients on Depot Injections. Repeat Surveys over 18 years’, British Journal of Psychiatry, 56 (1990), 827–34.CrossRefGoogle Scholar
  10. 2.
    Tyrer, P., ‘Benefits and Risks of Benzodiazepines. The Benzodiazepines in Current Clinical Practice’, The Royal Society of Medicine International Congress and Symposium Series, 114 (1987), pp. 7–11.Google Scholar
  11. 3.
    Murray, J., in Gabe, J. and Williams, P. (eds), Tranquillisers: Social, Psychological, and Clinical Perspectives (London: Tavistock, 1986).Google Scholar
  12. 4.
    Lacey, R., The Mind Complete Guide to Psychiatric Drugs (London: Ebury Press, 1991).Google Scholar
  13. 5.
    Warner, R., ‘Antipsychotic Drugs: Use, Abuse and Non-use’, in Recovery from Schizophrenia: The Political Economy of Psychiatry (London: Routledge & Kegan Paul, 1985), pp. 239–67.CrossRefGoogle Scholar
  14. 6.
    Mayer-Gross, W., Slater, E. and Roth, M., Clinical Psychiatry (London: Baillière, Tindall and Cassell, 1969), p. 805.Google Scholar
  15. 7.
    Heath, A., ‘Toxicity of Antidepressants with Special Reference to Overdose and Suicide’, in Proceedings of a Symposium held in Stratford-upon-Avon (Stratford: Franklin Scientific Publications, 1983), p. 21.Google Scholar
  16. 8.
    Royal College of Psychiatrists, The Use of Electro-Convulsive Therapy (London, 1977).Google Scholar
  17. 8a.
    See also Consensus Development Statement, Electro-Convulsive Therapy (Los Angeles: American Psychiatric Association, 1985).Google Scholar
  18. 9.
    Kellam, A.M.P., The Neuroleptic Syndrome, So-called: A Survey of the World Literature, British Journal of Psychiatry, 150 (1987), pp. 752–9;CrossRefGoogle Scholar
  19. 9a.
    Abbott, R.J. and Loizou, L.A., ‘Neuroleptic Malignant Syndrome’, British Journal of Psychiatry, 148 (1986), pp. 47–51.CrossRefGoogle Scholar
  20. 11.
    The dangers and consequences of tranquilliser dependence have generated an extensive literature and the desirablity of talking treatment alternatives to tranquillisers is a constantly recurring theme, particularly in books written for and by lay persons. See, for example: Lacey, R. and Woodward, S., That’s Life Survey on Tranquillisers (London: BBC Publications; MIND, Finding Our Own Solutions: Women’s Experiences of Mental Health Care (London: MIND, 1986).Google Scholar
  21. 12.
    Szasz, T., The Myth of Psychotherapy (Oxford University Press, 1979), p. 1.Google Scholar
  22. 13.
    Belmaker, R. H. and Wald, D., ‘Haloperidol in Normals’, British Journal of Psychiatry, 131 (1977), p. 222.CrossRefGoogle Scholar
  23. 15.
    Ryall, D., ‘Review. The Complete Guide to Psychiatric Drugs: A Layman’s Guide. Lacey, R. Ebury Press. London’, NSF News, 3 (1991), p. 5.Google Scholar
  24. 16.
    Mental Health Act Commission, Third Biennial Report 1988–1989 (London: HMSO, 1989), p. 24(i).Google Scholar
  25. 17.
    Mitchell, J. E. and Popkin, M. K., ‘Antipsychotic Drug Therapy and Sexual Dysfunction in Men’, American Journal of Psychiatry, 139 (1982), pp. 633–7.CrossRefGoogle Scholar
  26. 18.
    Leff, J. P. and Wing J. K., ‘Trial of Maintenance Therapy in Schizophrenia’, British Medical Journal, 5 (1971), pp. 559–606.Google Scholar
  27. 19.
    Cole, J. O., Goldberg, S. C. and Klerman, G. L., ‘Phenothiazine Treatment in Acute Schizophrenia’, Archives of General Psychiatry, 10 (1964), pp. 246–61.CrossRefGoogle Scholar
  28. 20.
    Crow, T. J., Macmillan, J. S., Johnson, A. L. and Johnson, E. C., ‘The Northwick Park Study of First Episodes of Schizophrenia; A Controlled Study of Neuroleptic Treatment’, British Journal of Psychiatry, 148 (1986), pp. 120–7.CrossRefGoogle Scholar
  29. 22.
    Ochsenfahrt, H., ‘Second Generation Antidepressants: Therapeutic Effects and Side Effects Profile’, in Advances in Antidepressant Therapy, International Medicine Supplement Number 10, sponsored by E.Merck Limited, 1984.Google Scholar
  30. 22a.
    Leonard, B. E., ‘New Antidepressants and the Biology of Depression’, Stress Medicine, 1 (1985), pp. 9–16.CrossRefGoogle Scholar
  31. 22b.
    Levine, S., Deo, R. and Mahadevan, K., ‘A Comparative Trial of a New Antidepressant, Fluoxetine’, British Journal of Psychiatry, 150 (1987), pp. 653–5.CrossRefGoogle Scholar
  32. 23.
    Sireling, L. I., Freeling, P., Paykel, E. S. and Rao, B. M., ‘Depression in General Practice: Clinical Features and Comparison with Out-Patients’, British Journal of Psychiatry, 147 (1985), pp. 119–26.CrossRefGoogle Scholar
  33. 24.
    Brandon, S., ‘Management of depression in general practice’, British Medical Journal, 292 (1986), pp. 287–8.CrossRefGoogle Scholar
  34. 26.
    Spiegel, R., Psychopharmacy: An Introduction (New York: Wiley, 1989) p. 14.Google Scholar
  35. 30.
    Balter, M.B., Manheimer, D.I., Mellinger, G.D. and Uhlenhuth, E.H., ‘A Cross National Comparison of Anti-anxiety/sedative Drug Use’, Current Medical Research Opinion, Suppl. 4 (1984), pp. 5–20.Google Scholar
  36. 31.
    Committee on the Review of Medicines, ‘Systematic Review of the Benzodiazepines’, British Medical Journal, 280, 6218 (1980), pp. 910–12.CrossRefGoogle Scholar
  37. 32.
    CSM, ‘Benzodiazepines, Dependence and Withdrawal Symptoms’, Current Problems, 21 (1988), pp. 220–8.Google Scholar
  38. 33.
    Consensus Development Conference Statement, Electroconvulsive Therapy (National Institute of Mental Health, 1985) p. 2.Google Scholar
  39. 35.
    Johnstone, E. C., Deakin, J.F.W., Lawler, P., Frith, C. D., Stevens, M., McPherson, K. and Crow, T. J. (1980), ‘The Northwick Park Electroconvulsive Therapy Trial’, The Lancet (1980);Google Scholar
  40. 35a.
    Brandon, S., Cowley, P., Mcdonald, C., Neville, P., Palmer, R. and Wellstood-Easton, P., ‘Electroconvulsive therapy: Results in Depressive Illness from the Leicestershire Trial’, British Medical Journal, 288 (1984), pp. 22ff.CrossRefGoogle Scholar
  41. 36.
    Department of Health, ‘Electro-Convulsive Therapy Statistics. England. National and Regional Summaries for the Financial Year 1987/88’ (London: Statistics and Management Information Division, 1989).Google Scholar
  42. 37.
    Royal College of Psychiatrists, The Practical Administration of Electroconvulsive Therapy (London: Gaskell 1989).Google Scholar
  43. 38.
    Anon, ‘View from the bottom’, Psychiatric Bulletin, 14 (1990), p. 452.CrossRefGoogle Scholar
  44. 39.
    Eysenck, H. J., ‘The Effects of Psychotherapy: An Evaluation’, Journal of Consulting Psychology, 16 (1952), pp. 319–24.CrossRefGoogle Scholar
  45. 40.
    Huxley, D. P., Goldberg, D.P., Maguire, G.P. and Kincey, G.P., ‘The Prediction of the Course of Minor Psychiatric Disorders’, British Journal of Psychiatry, 135 (1979), pp. 535–43.CrossRefGoogle Scholar
  46. 43.
    Leff, J., Kuipers, L. and Berkowitz, R. A., ‘Trial of Social Interventions in the Families of Schizophrenic Patients’, British Journal of Psychiatry, 141 (1982), pp. 121–34.CrossRefGoogle Scholar
  47. 43a.
    Falloon, I.F.H., Boyd, J.L., McGill, C.W., Razani, J., Moss, H. B., and Gilderman, A. M., ‘Family Management in the Prevention Exacerbation of Schizophrenia: A Controlled Study’, New England Journal of Medicine, 306 (1982), pp. 1437–40.CrossRefGoogle Scholar
  48. 44.
    Lambert, M.J., Shapiro, D. A. and Bergin, A. E., ‘The Effectiveness of Psychotherapy’, in Garfield, S. L. and Bergin, A. E. (eds), Handbook of Psychotherapy and Behaviour Change, 3rd edn (Chichester: Wiley, 1986).Google Scholar
  49. 45.
    Brown, L. S., ‘Harmful Effects of Post-Termination Sexual and Romantic Relationships between Therapists and their Former Clients’, Psychotherapy (1988), pp. 249–55.Google Scholar
  50. 46.
    Masson, J. M., Against Therapy, Warning: Psychotherapy can be Dangerous to your Mental Health (London: Collins 1989);Google Scholar
  51. 46a.
    Smail, D., Taking Care: An Alternative to Therapy (London: Dent, 1988).Google Scholar

Copyright information

© Anne Rogers, David Pilgrim and Ron Lacey 1993

Authors and Affiliations

  • Anne Rogers
  • David Pilgrim
  • Ron Lacey

There are no affiliations available

Personalised recommendations